Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000971

Drug Information
SynonymsD00969; (3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1; CCRIS 9139; Mobic (TN); Masflex; LS-40538; Bio-0826; DB00814; Gen-meloxicam; Movicox; Movatec; Novo-meloxicam; 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide; Abbott brand of meloxicam; Uticox; Meloxivet; AKOS000279442; SPECTRUM1504150; Squibb brand of meloxicam; C08169; AC1Q3XZW; UHAC-62XX; 133687-22-6; Meloxicam [USAN:BAN:INN]; FT-0082769; STK620505; HMS2089B18; Mobicox; 4-hydroxy-2-mehtyl-N-(5-mehtyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methylthiazolyl)-, 1,1-dioxide; 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; Mobic, Metacam, Parocin, Meloxicam; I06-0490; S1734_Selleck; M1959; C065757; Boehringer Ingelheim brand of meloxicam; Ratio-meloxicam; Dom-meloxicam; Mobec; 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide; Movalis; Parocin; Meloxicam (JAN/USAN/INN); CHEMBL599; PMS-meloxicam; Europharma brand of meloxicam; TL8005001; Almirall brand of meloxicam; Co Meloxicam; 71125-38-7; Metacam; Meloxicamum; CID5281106; PHL-meloxicam; AC1NQY12; Meloxicamum [Latin]; UNII-VG2QF83CGL; HMS1922D19; Tenaron; Apo-meloxicam; reumoxicam; UH-AC 62XX; MolPort-002-885-839; AC-1325; Promeco brand of meloxicam; C14H13N3O4S2; Mobic; miloxicam; meloxicam; 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazoyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide    
Trade NameMovalis; Melox; Recoxa; Moxen; Mobic; Mobec; Mobicox; Tenaron; Ilacox; Melocam    
CompanyBoehriger Ingelheim    
IndicationArthritisApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntiinflammatory Agents    
CAS NumberCAS 71125-38-7
PubChem Compound IDCID 5281106.    
PubChem Substance IDSID 10369.    
SuperDrug ATC IDM01AC06;    
SuperDrug CAS ID071125387;    
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Variability in the response to cyclooxygenase inhibitors: toward the individualization of nonsteroidal anti-inflammatory drug therapy. J Investig Med. 2009 Aug;57(6):709-16. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543